Marathon Capital Management’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,700
Closed -$484K 159
2022
Q2
$484K Buy
+2,700
New +$689K 0.16% 91
2022
Q1
Sell
-2,592
Closed -$959K 128
2021
Q4
$959K Sell
2,592
-623
-19% -$236K 0.22% 66
2021
Q3
$1.27M Buy
3,215
+639
+25% +$294K 0.29% 58
2021
Q2
$1.19M Sell
2,576
-103
-4% -$41.5K 0.27% 57
2021
Q1
$1M Sell
2,679
-10
-0.4% -$4.08K 0.26% 56
2020
Q4
$967K Buy
2,689
+402
+18% +$128K 0.29% 57
2020
Q3
$687K Buy
+2,287
New +$788K 0.25% 61

Other funds holding ILMN

Marathon Capital Management's ILMN Position: Q3 2022 in Review

Marathon Capital Management sold out of Illumina (ILMN) in Q3 2022, closing a stake of 2,700 shares — an estimated $484K sold.

Marathon Capital Management first reported a position in ILMN in Q3 2020 and held it in 7 quarters. The position peaked at $1.27M in Q3 2021. 897 funds tracked by Wall St. Rank hold ILMN as of Q3 2022.

  • Marathon Capital Management reported no remaining Illumina position as of Q3 2022 after selling out during the quarter.
  • Marathon Capital Management sold 2,700 Illumina shares in Q3 2022, an estimated $484K.
  • Marathon Capital Management first reported a position in Illumina in Q3 2020 and held it in 7 quarters.
  • Marathon Capital Management's Illumina position peaked at $1.27M in Q3 2021.
  • 897 funds tracked by Wall St. Rank held Illumina as of Q3 2022.

Based on Marathon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.